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 …is a substance produced by a microorganism, that 
has the capacity, in dilute solution, to selectively 
inhibit or kill other microorganisms (Paul Vuillemin 
1941) 
An antibiotic 
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 …refers to any substance that can affect    
microbial life - including synthetic and 
semi-synthetic substances and compounds 
without selective toxicity (e.g. 
disinfectants) 
 
 
 
 
An ’antimicrobial agent’ 
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Origin and activity 
Class Origin Activity  
Aminoglycosides   Streptomyces sp, Micromonospora  sp Bactericidal 
Cephalosporins Cephalosporium spp Bactericidal 
Macrolides Streptomyces spp Bacteriostatic 
Penicillins Penicillium sp Bactericidal 
Phenicols Streptomyces venezuelae Bacteriostatic 
Quinolones Synthetic Bactericidal 
Rifamycins Amycolatopsis mediterranei  Bactericidal 
Sulfonamides Synthetic Bacteriostatic 
Tetracyclines Streptomyces spp Bacteriostatic 
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What is antimicrobial resistance? 
 Microbiological definition: 
– Resistance is the property of a bacterial strain to survive at 
higher antibiotic concentrations compared to most other 
members of the same species (wild types) 
 
 Clinical definition: 
– Resistance is the ability of a bacterial strain to survive 
antimicrobial therapy 
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Intrinsic resistance 
 Resistance due to a structural or functional trait allowing tolerance 
by all members of a bacterial group (species, genus or even larger 
group) 
– Impermeability 
– Active exporters 
– Enzymatic degradation 
– Low affinity of the target 
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Example of intrinsic resistance  
 
Cefotaxime susceptibility in E. coli and 
Acinetobacter baumannii 
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Types of acquired resistance 
 Mutation (endogenous, vertical) 
 
 Gene transfer (exogenous, horizontal) 
– Transformation (free DNA) 
– Transduction (with phages) 
– Conjugation (plasmids) 
 
17/04/2008 Presentation name 9 DTU Food, Technical University of Denmark 
Targets of antimicrobial action 
Folate metabolism 
Sulfonamides 
Trimethoprim 
Cell wall synthesis 
Vancomycin 
β-lactams, e.g.: 
  Penicillin 
  Cephalosporins 
  Monobactams 
  Carbapenems 
 
Cell membrane 
Polymyxin 
Amphotericin 
Protein synthesis 
inhibitors (50S) 
Macrolides 
Chloramphenicol 
Clindamycin 
Protein synthesis 
Inhibitors (30S) 
Tetracyclines 
Aminoglycosides 
Fucidinic acid 
DNA replication 
Fluoroquinolones 
Metronidazole 
RNA-polymerase 
Rifampicin 
17/04/2008 Presentation name 10 DTU Food, Technical University of Denmark 
Glycopeptides, 
e.g. Vancomycin β-lactams e.g. 
penicillin 
Inhibition on cell wall synthesis 
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Glycopeptides, 
e.g. Vancomycin β-lactams e.g. 
penicillin 
Resistance mechanism 
   
  
 
 
 
Against β-lactams: 
1. Mutations in the target PBP or acquisition of new PBP’s with decreased 
affinity for the drug 
2. Producing one or more β-lactamases 
3. Change the cell wall porins  
4. Active efflux-pump 
 
Against glycopeptides: 
1. Synthesis of D-Ala-D-Lac in stead of D-Ala-D-Ala 
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Folate pathway inhibitor 
 
 
Figure from cdc.gov:  
PABA paraaminobenzoic acid 
DHPS, dihydropteroate synthase 
DHFR, dihydrofolate reductase 
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Folate pathway 
 
 
Figure from cdc.gov:  
PABA paraaminobenzoic acid 
DHPS, dihydropteroate synthase 
DHFR, dihydrofolate reductase 
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Against sulfonamides: 
1. Sulfonamide-insensitive enzymes are produced 
Against trimethoprim: 
1. Trimethoprim-insensitive enzymes are produced 
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Inhibition of DNA synthesis 
Quinolones appear to mainly target gyrA in G- and parC in G+ 
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Resistance mechanism 
Quinolones appear to mainly target gyrA in G- and parC in G+ 
   
  
 
1. Target mutations in the topoisomerase genes 
2. Decrease permeability of the cell wall 
3. Active efflux-pump 
 
High-level fluoroquinolone-resistance: primarily due to mutations in gyrA 
and parC-genes 
 => reduce binding of the drug, and DNA replication can continue 
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Inhibition of protein synthesis I 
Figure from McDermott et. al., 2003, International Journal of Toxicology, 22:135–143 
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Inhibition of protein synthesis II 
Figure from McDermott et. al., 2003, International Journal of Toxicology, 22:135–143 
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Resistance mechanism 
Against aminoglycosides (e.g. strep, gen): 
1. Structural mutations in the 30S ribosomal sub-unit 
2. Production of modifying enzymes (a large number of diverse enzymes 
have been identified) 
Against chloramphenicol: 
1. Inactivation of the drug by acetylation of the two hydroxyl groups 
2. Efflux mechanisms 
Against macrolides (e.g. ery): 
1. G- are intrinsically resistant 
2. Mutations or modifications (methylation) of the 23S ribosomal RNA 
subunit 
3. Efflux-pump 
 
 
 
 
 
 
 
 
 
 
 
 
 
Against tetracycline: 
1. Modifications of the ribosome 
2. Efflux-pump 
Against streptogramins: 
1. Inactivation by acelylation 
2. Ribosomal mutations 
Against linezolid: 
1. Mutations in the 23S rRNA subunit 
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Mechanisms of resistance 
1. Alteration of the antimicrobial agent Aminoglycosides, 
chloramphenicol, β-lactams, 
Streptogramins 
2. Mutation in the target site Aminoglycosides, β-lactams, 
macrolides, quinolones, 
rifampicin, trimethoprim, 
tetracycline, mupirocin 
3. Decreased antibiotic accumulation 
- Decreased uptake 
- Increased efflux  
 
Many antibiotics 
Tetracycline, macrolides, 
chloramphenicol and 
quinolones 
4. Acquisition of drug-insensitive 
enzyme 
Sulfonamides, trimethoprim 
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 Resistance to two related (avoparcin / vancomycin) or unrelated 
drugs (erythromycin / lincosamides) is due to a single biological 
mechanism 
 
Cross resistance 
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Thanks for your attention! 
 
